Form 4 for TECH Bio-Techne
Accepted 2022-08-09 00:00:00 ET · period of report 2022-08-07 · accession 0001437749-22-019667 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-09 | 2022-08-07 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | +2,363 | 4,352 | +119% | $0 |
| D | 2022-08-09 | 2022-08-07 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | F - Tax | $382.97 | -1,214 | 3,138 | -28% | -$464.9K |
| D | 2022-08-09 | 2022-08-07 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | -2,363 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-07 | M | A | 2,363 | $0.00 | 4,352 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-07 | F | D | 1,214 | $382.97 | 3,138 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-08-07 | M | D | 2,363 | $0.00 | 0 | D | — · — to — | 2,363 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F3) On 8/7/2022, the Board of Directors certified vesting of 2,363 performance RSUs. |